Sam Litwin
- Immunology top 5%
- T-cell and B-cell Immunology 3
-
- Monoclonal and Polyclonal Antibodies Research 3
- Hepatology top 10%
-
- Cancer Treatment and Pharmacology 3
-
- Lung Cancer Treatments and Mutations 6
-
- Hepatitis B Virus Studies 5
-
- Viral gastroenteritis research and epidemiology 4
-
- Genetic factors in colorectal cancer 4
-
- Animal Virus Infections Studies 4
Sam Litwin
25 papers receiving 923 citations
Peers
Comparison fields: 5 of 73
- Immunology 514
- Radiology, Nuclear Medicine and Imaging 244
- Hepatology 81
- Oncology 180
- Hematology 67
Countries citing papers authored by Sam Litwin
This map shows the geographic impact of Sam Litwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sam Litwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sam Litwin more than expected).
Fields of papers citing papers by Sam Litwin
This network shows the impact of papers produced by Sam Litwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sam Litwin. The network helps show where Sam Litwin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sam Litwin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2015 | 4 | |
| 4 | 2015 | 7 | |
| 5 | 2012 | 22 | |
| 6 | 2011 | 5 | |
| 7 | 2010 | 6 | |
| 8 | 2007 | 23 | |
| 9 | 2005 | 31 | |
| 10 | 2002 | 6 | |
| 11 | 2002 | 26 | |
| 12 | 2000 | 27 | |
| 13 | Paclitaxel (1-hour) and carboplatin (area under the concentration-time curve 7.5) in advanced non-small cell lung cancer: a phase II study of the Fox Chase Cancer Center and its network. | 1997 | 8 |
| 14 | Combination paclitaxel (1-hour) and carboplatin (AUC 7.5) in advanced non-small cell lung cancer: a phase II study by the Fox Chase Cancer Center Network. | 1996 | 6 |
| 15 | Paclitaxel by 24- or 1-hour infusion n combination with carboplatin in advanced non-small cell lung cancer: the Fox Chase Cancer Center experience. | 1995 | 8 |
| 16 | 1994 | 149 | |
| 17 | 1993 | 331 | |
| 18 | 1991 | 3 | |
| 19 | 1990 | 84 | |
| 20 | 1984 | 94 |
About Sam Litwin
Sam Litwin is a scholar working on Animal Science and Zoology, Hepatology and Infectious Diseases, having authored 26 papers that have together received 945 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (6 papers), Hepatitis B Virus Studies (5 papers), Viral gastroenteritis research and epidemiology (4 papers), Genetic factors in colorectal cancer (4 papers), Animal Virus Infections Studies (4 papers), Cancer Treatment and Pharmacology (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and T-cell and B-cell Immunology (3 papers). The work is most often cited by research in Immunology (514 citations), Radiology, Nuclear Medicine and Imaging (244 citations) and Hepatology (81 citations). Sam Litwin has collaborated with scholars based in United States, Australia and Poland. Frequent co-authors include Marko Radic, Martin Weigert, Jan Erikson, Kara B. Anthony, Beatrice Mintz, Martin Weigert, Sally A. Camper, J Erikson, Peter J. O’Dwyer and Louis M. Weiner. Their work appears in journals such as Journal of Clinical Oncology, Journal of Virology, Seminars in Immunology, The Journal of Experimental Medicine and Virus Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.